B

BioCryst Pharmaceuticals

Develops oral drugs for rare diseases

Director Scientific Communications

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNorth Carolina, USANo salary listedRemote

About the Job

Requirements

  • An advanced scientific or clinical degree is required, such as a PharmD, PhD, MD, DO, or equivalent.
  • At least 10 years of progressive experience in Medical Affairs, scientific engagement, field medical, medical education, publications, Clinical Development, or related pharmaceutical or biotechnology functions is required.
  • Demonstrated success leading scientific engagement initiatives that support disease-state education, external expert engagement, launch readiness, evidence dissemination, and lifecycle priorities is required.
  • Advanced scientific acumen and the ability to interpret complex clinical, translational, real-world, and competitive evidence and translate data into strategic scientific direction are required.
  • Experience developing and executing KOL, external expert, advisory board, stakeholder engagement, and insight-generation plans within a compliant Medical Affairs environment is required.
  • Substantial experience supporting launch readiness, launch execution in highly competitive environments, or lifecycle optimization through external insights, stakeholder engagement, field medical enablement, congress input, and Medical Affairs planning is required.
  • The ability to partner effectively with Medical Education and Communications and collaborate across Medical Affairs, Clinical Development, Publications, Regulatory, Commercial, Market Access, Field Medical, external experts, and agency partners is required.
  • A comprehensive understanding of pharmaceutical industry compliance requirements, medical/legal/regulatory review processes, and ethical standards governing scientific exchange is required.
  • The ability to communicate, collaborate, lead projects, and manage stakeholders effectively while influencing in a matrixed environment is required.
  • The ability to operate with executive presence and strategic agility, while maintaining rigorous attention to scientific accuracy, operational excellence, compliance, and business priorities, is required.

Responsibilities

  • Lead scientific engagement priorities for assigned assets, indications, or therapeutic areas across disease-state strategy, launch planning, lifecycle management, and evidence dissemination.
  • Interpret clinical, translational, real-world, and competitive evidence into strategic scientific direction that informs Medical Affairs planning and priorities, along with external engagement.
  • Lead external expert engagement, advisory board planning, KOL and stakeholder strategies, and insight-generation activities to inform scientific and medical priorities.
  • Lead Medical Education and Communications direct reports and related activities to ensure scientific engagement insights, external expert perspectives, and Medical Affairs priorities are reflected in communication planning and related deliverables.
  • Provide strategic scientific input to congress planning, medical education, field medical resources, and external communication planning in collaboration with Medical Education and Communications and cross-functional partners.
  • Partner cross-functionally with Medical Affairs, Clinical Development, Publications, Regulatory, Commercial, Market Access, Field Medical, and Patient Advocacy to ensure scientific alignment and coordinated execution.
  • Advance launch readiness and lifecycle excellence in highly competitive environments by aligning external insights, stakeholder engagement priorities, scientific direction, field medical enablement, congress strategy, and Medical Affairs planning.
  • Monitor the scientific, clinical, regulatory, and competitive landscape to identify implications for scientific engagement, education, stakeholder planning, and lifecycle priorities.
  • Ensure scientific engagement activities and related inputs are accurate, balanced, evidence-based, strategically aligned, and compliant with applicable policies and review processes.
  • Oversee agency and vendor partners supporting scientific engagement activities, including scope development, budget stewardship, timeline management, quality oversight, and performance feedback.
  • Ensure finance and governance discipline for scientific engagement and medical education and communication activities, including budget forecasting, resource prioritization, compliant review processes, and responsible management of project spend.
  • Serve as a scientific advisor and subject matter expert, supporting leadership decision-making and executive-level communication of complex scientific topics.

Desired Qualifications

  • Experience in rare disease, immunology, or other relevant therapeutic areas is preferred; experience across multiple therapeutic areas, with the ability to quickly develop disease-state fluency and apply scientific engagement approaches across diverse clinical landscapes, is also preferred.
  • Prior leadership experience in Medical Affairs roles focused on scientific engagement, external expert engagement, advisory board planning, insight generation, or field medical enablement is preferred.
  • Experience partnering with Medical Education and Communications, Publications, or agency partners to translate scientific insights and Medical Affairs priorities into aligned communication planning is preferred.
  • Experience working in matrix environments, including collaboration with priority markets and cross-functional launch teams, is preferred.
  • Experience with evidence generation planning, real-world evidence interpretation, advisory board planning, or investigator-sponsored research processes is preferred.
  • Demonstrated success providing oversight of agency partners, managing budgets, and delivering high-quality scientific engagement activities within established timelines is preferred.

About the Company

BioCryst Pharmaceuticals

Develops oral drugs for rare diseases

BioCryst Pharmaceuticals develops oral small-molecule drugs aimed at treating rare diseases, with a focus on hereditary angioedema (HAE). The company uses traditional cell biology and medicinal chemistry to design synthetic compounds that target specific protein pathways involved in disease. Its products work as oral therapies that modulate disease-related proteins to reduce symptoms and improve daily functioning, progressing from discovery through clinical trials toward commercialization. BioCryst differentiates itself by concentrating on rare diseases and pursuing oral, non-biologic treatments, leveraging a combined science approach and a patient-focused strategy to bring therapies to market. Its goal is to deliver meaningful, clinically validated treatments that enable patients to engage more fully in everyday activities and improve their quality of life, supported by its drug pipeline and potential licensing opportunities.

Company size
501-1,000
Company stage
IPO
Headquarters
Durham, NC
Founded
1986

Recently Posted Jobs

Explore more opportunities at BioCryst Pharmaceuticals

See more jobs